Cognitive Profiling and Validation of a Digital Cognitive Assessment Tool in Post-COVID-19 Condition: Protocol for a Single-Center, Cross-Sectional Study (DigiCog Study)

The DigiCog study is a single-center, cross-sectional protocol designed to validate a digital cognitive assessment tool (VMTech) against standardized neuropsychological tests and to profile cognitive performance in Luxembourgish adults with and without Post-COVID-19 Condition.

The Gist

Imagine your brain as a high-performance sports car. For most people, it runs smoothly. But for some, after a viral "engine trouble" like COVID-19, the car starts making strange noises. The driver (the patient) feels fine, but the dashboard lights are flickering. They might feel foggy, forgetful, or unable to focus. This is Post-COVID-19 Condition (PCC), often called "Long COVID."

The DigiCog Study is like a team of expert mechanics and engineers trying to figure out exactly what's wrong with these cars, and testing a brand-new, futuristic diagnostic tool to see if it can spot the problems better than the old-school methods.

Here is a simple breakdown of what they are doing:

1. The Problem: The "Brain Fog" Mystery

Many people who survived COVID still feel like their brain is running on "low battery." They struggle with memory, attention, or speed. Doctors know this happens, but it's hard to measure. It's like trying to describe a ghost; you know it's there, but you can't catch it with a net.

• The Goal: The researchers want to map out exactly where the engine is sputtering. Is it the memory part? The attention part? Or the speed part?

2. The Old Tool vs. The New Tool

To find the problem, the study compares two different ways of testing the brain:

• The Old Tool (The Pen-and-Paper Test): This is the traditional way doctors check your brain. It involves a neuropsychologist sitting with you, asking you to name as many animals as you can in a minute, draw a clock, or remember a list of words. It's like a mechanic using a wrench and a flashlight to check the engine. It's reliable, but it takes time and depends on the mechanic's eyes.
• The New Tool (The "Eye-Tracking" Goggles): This is the star of the show. The researchers are testing a digital headset made by a company called ViewMind. Instead of asking you to speak or write, you just look at a screen. The headset tracks your eye movements at lightning speed (120 times a second).
  • The Analogy: Imagine your eyes are the steering wheel of the car. Even if you don't say anything, the way your eyes move, pause, or dart around reveals how your brain is thinking. If your brain is slow, your eyes might hesitate. If your attention is broken, your eyes might wander. This tool is like a super-sensitive GPS that records every tiny turn your eyes make to diagnose the engine trouble.

3. The "Reserve Tank" (Cognitive Reserve)

The study also looks at something called Cognitive Reserve. Think of this as a "mental savings account" or a "backup battery" you build up over your life.

• How do you build it? By learning languages, having a complex job, going to school, or doing fun, brainy hobbies.
• Why does it matter? The researchers want to know: Do people with a bigger "backup battery" (more education, more languages) handle the COVID "engine trouble" better? Maybe their brains are just more resilient, like a car with a reinforced chassis that can handle a bump without breaking.

4. How the Study Works

The researchers are driving this experiment using a group of people from a previous study called "Predi-COVID."

• The Drivers: They invited 199 people (aged 25–65) who had COVID. Some still feel sick (the "PCC group"), and some feel totally fine (the "control group").
• The Test Drive: Each person comes in for two sessions.
  1. They do the old-school paper tests with a nurse or psychologist.
  2. They put on the high-tech eye-tracking headset and play some simple eye-games (like following arrows or remembering patterns).
• The Comparison: The researchers will compare the results. Does the high-tech headset agree with the paper test? If the headset says "Attention is low," does the paper test say the same thing?

5. Why This Matters

If this new "Eye-Tracking Goggles" tool works as well as the old paper tests, it changes the game:

• Speed: It's faster.
• Fairness: It doesn't matter if you speak French, German, or English; your eyes speak the same language.
• Accessibility: It could be used in regular doctor's offices, not just fancy research labs, to catch brain fog early.

The Bottom Line

The DigiCog study is a detective story. They are trying to solve the mystery of why some people's brains struggle after COVID. They are testing if a futuristic, eye-tracking gadget can be the new "stethoscope" for the brain, while also figuring out if a lifetime of learning and challenges acts as a shield against these problems.

Current Status: They have finished testing the drivers (199 people) and are now crunching the numbers. The final report, which will tell us if the new gadget works, is expected in late 2026.

Technical Summary

1. Problem Statement

• Post-COVID-19 Condition (PCC) Cognitive Impairment: Cognitive deficits (e.g., attention, memory, processing speed) are among the most prevalent and disabling persistent symptoms of PCC (Long COVID). However, the specific cognitive profiles are heterogeneous, and the mechanisms driving interindividual variability remain poorly understood.
• Limitations of Current Assessment: Traditional neuropsychological testing is often time-consuming, examiner-dependent, and difficult to scale for large populations. Conversely, digital cognitive tools are emerging but lack rigorous validation in post-infectious contexts.
• The Role of Cognitive Reserve (CR): While CR (shaped by education, occupation, and multilingualism) is known to buffer against neurodegenerative decline, its specific role in moderating cognitive outcomes following SARS-CoV-2 infection is largely unexplored.
• Need for Validation: There is an urgent need to validate scalable, examiner-independent digital assessment tools (specifically eye-tracking based) against gold-standard neuropsychological measures to facilitate early screening and monitoring in primary care.

2. Methodology

The DigiCog study is a single-center, cross-sectional validation study embedded within the longitudinal Predi-COVID cohort (NCT04380987) in Luxembourg.

• Study Population:

  • Target: Adults aged 25–65 years, non-hospitalized, residing in Luxembourg.
  • Groups: Participants are stratified into two groups based on PCC symptom status:
    • Case Group: Individuals reporting persistent symptoms (per WHO criteria).
    • Control Group: Asymptomatic individuals or those with resolved symptoms.
  • Exclusion Criteria: Traumatic brain injury, stroke, epilepsy, chronic fatigue syndrome (within the last 7 years), and severe visual impairments (e.g., color blindness, diplopia).
  • Sample Size: As of March 2025, 199 participants were enrolled (target was 200). Power calculations indicated sufficient power to detect moderate-to-large effect sizes in group comparisons and agreement between assessment methods.

• Data Collection & Procedures:

  • Design: A cross-sectional evaluation where participants serve as their own controls. Assessments are conducted in a counterbalanced order (digital vs. standard) to mitigate order effects.
  • Standard Neuropsychological Assessment (Gold Standard): Administered by trained neuropsychologists using the CERAD-NP-plus battery, MMSE, Stroop Test, Symbol Digit Modalities Test (SDMT), Clock Drawing Test, and Trail Making Test. Tests are administered in French or German based on participant preference.
  • Digital Cognitive Assessment (VMTech): Administered by trained nurses using a ViewMind (VMTech) eye-tracking headset.
    • Tasks: Go/No-Go (inhibitory control), Spatial N-Back (working memory), and Visual Short-Term Memory Binding (VSTMB).
    • Metrics: Eye-tracking data (fixations, saccades, pupil dilation) recorded at 120 Hz.
  • Covariates & Modifiers:
    • Cognitive Reserve (CR): Assessed via the Cognitive Reserve Index Questionnaire (CRIq), multilingualism, occupational history, and leisure activities.
    • Psychological/Physical Factors: Fatigue (FACIT-Fatigue), Anxiety/Depression (BAI/BDI-II), and subjective cognitive complaints.

• Statistical Analysis Plan:

  • Preprocessing: Raw scores adjusted for age, education, sex, and multilingualism using linear regression models (OLS or robust MM-estimation).
  • Validation Metrics: Agreement between digital and standard tools measured via Cohen's kappa, sensitivity, specificity, and ROC curve analysis (AUC).
  • Group Comparisons: ANCOVA models to compare cognitive profiles between PCC and non-PCC groups, controlling for demographics.
  • CR Analysis: Multivariable regression to explore the association between CR proxies and cognitive performance.

3. Key Contributions

• Validation of Eye-Tracking Technology: The study provides a rigorous framework for validating a novel, proprietary eye-tracking medical device (ViewMind) against established pen-and-paper neuropsychological standards specifically for PCC.
• Granular Cognitive Profiling: Unlike studies relying on global cognitive scores, DigiCog analyzes condition-specific subtest scores to detect subtle, domain-specific deficits (e.g., executive dysfunction) characteristic of PCC.
• Integration of Cognitive Reserve: It is one of the first studies to systematically investigate how CR proxies (education, multilingualism, occupation) modulate cognitive recovery in post-infectious syndromes.
• Methodological Rigor: The study employs a "blinded" validation approach where the research team (LIH) does not have access to the proprietary algorithms of the device manufacturer (ViewMind), ensuring objective evaluation of the device's output.

4. Results

• Current Status: As of the publication date (April 2026), data collection is complete (199 participants enrolled).
• Data Processing: The final database was locked in December 2025.
• Outcomes: Statistical analyses are ongoing. Consequently, specific quantitative results regarding agreement coefficients (kappa), effect sizes, or specific cognitive profiles are not yet available in this protocol paper. Results are anticipated for late 2026.

5. Significance

• Clinical Utility: If the digital tool demonstrates high validity, it could revolutionize PCC management by providing a scalable, language-independent, and rapid screening tool for primary care settings, reducing the burden on specialized neuropsychological services.
• Public Health Impact: By characterizing the specific cognitive deficits in PCC and identifying protective factors (Cognitive Reserve), the study can inform targeted rehabilitation strategies and lifestyle interventions.
• Future Research: The study sets a precedent for integrating digital biomarkers (eye-tracking) into the assessment of post-infectious neurological sequelae, potentially serving as a model for evaluating other emerging infectious diseases.
• Multilingual Context: The study's adaptation to Luxembourg's multilingual environment (French/German) offers insights into conducting cognitive assessments in diverse linguistic populations without compromising validity.